TipRanks
VISEN Pharmaceuticals (HK:2561)
:2561
Hong Kong Market
2561
VISEN Pharmaceuticals
RESEARCH TOOLSreports
Want to see HK:2561 full AI Analyst Report?

VISEN Pharmaceuticals (2561) Financial Statements

0 Followers

VISEN Pharmaceuticals Financial Overview

VISEN Pharmaceuticals's market cap is currently HK$2.21B. The company's EPS TTM is HK$-2.2; its P/E ratio is -7.37; VISEN Pharmaceuticals is scheduled to report earnings on August 27, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 160.73K¥ 2.78M¥ -1.67M¥ 0.00¥ 0.00
Gross Profit¥ 18.51K¥ 2.78M¥ -1.67M¥ -2.30M¥ -5.66M
Operating Income¥ -233.59M¥ -174.18M¥ -138.83M¥ -358.29M¥ -449.92M
EBITDA¥ -239.41M¥ -177.62M¥ -242.26M¥ -280.95M¥ -444.27M
Net Income¥ -246.86M¥ -182.24M¥ -249.57M¥ -288.97M¥ -486.18M
Balance Sheet
Cash & Short-Term Investments¥ 632.92M¥ 203.59M¥ 347.78M¥ 626.46M¥ 881.06M
Total Assets¥ 977.72M¥ 293.82M¥ 443.80M¥ 741.27M¥ 928.71M
Total Debt¥ 177.06M¥ 2.36M¥ 3.65M¥ 6.00M¥ 11.14M
Net Debt¥ -455.85M¥ -201.23M¥ -344.13M¥ -620.46M¥ -869.92M
Total Liabilities¥ 215.34M¥ 52.55M¥ 52.92M¥ 88.67M¥ 82.24M
Stockholders' Equity¥ 762.38M¥ 241.28M¥ 390.88M¥ 652.61M¥ 846.47M
Cash Flow
Free Cash Flow¥ -450.16M¥ -140.97M¥ -271.83M¥ -248.31M¥ -238.54M
Operating Cash Flow¥ -447.58M¥ -140.86M¥ -271.31M¥ -246.55M¥ -227.13M
Investing Cash Flow¥ 6.67M¥ -117.00K¥ -520.00K¥ -1.77M¥ -13.62M
Financing Cash Flow¥ 870.00M¥ -3.09M¥ -6.95M¥ -7.95M¥ 967.59M
Currency in CNY

VISEN Pharmaceuticals Earnings and Revenue History

Income Statement >

VISEN Pharmaceuticals Debt to Assets

Balance Sheet >

VISEN Pharmaceuticals Cash Flow

Cash Flow >

VISEN Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >